Pharma Equity Group A/S
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pharma Equity Group A/S
Pharma Equity Group AS is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develop technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement. Its drug candidates include RNX-011, RNX-021, RNX-022, RNX-023, RNX-041, and RNX-051 .
/ 
Frequently asked questions
To buy Pharma Equity Group A/S stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pharma Equity Group A/S by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pharma Equity Group A/S is PEG:xcse. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pharma Equity Group A/S has its primary listing on NASDAQ OMX Copenhagen. You can trade Pharma Equity Group A/S with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pharma Equity Group A/S is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Pharma Equity Group A/S as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Pharma Equity Group A/S.